INMB$1.36-1.81%
Inmune Bio, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$37.61M
Float & O/S:
Inst Own:
DilutionScan read 33 of Inmune Bio, Inc.'s SEC filings and found 6 warrant series, 3 ATM programs, 1 shelf registration and 2 completed offerings on file for INMB. Analysis updated Oct 29, 2026.